World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
81
Citations
21473
World Ranking
1581
National Ranking
110

Enno Schmidt publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Enno Schmidt sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 428 publications — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Enno Schmidt D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Enno Schmidt sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 81 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Enno Schmidt is affiliated with the University of Lübeck in Germany and has a substantial research portfolio in medicine, with a focus on pathology, rheumatology, genetics, dermatology, and immunology. Their work primarily addresses autoimmune bullous skin diseases, urticaria and related conditions, coagulation disorders involving bradykinin and polyphosphates, platelet disorders, dermatology and skin diseases, eosinophilic disorders, and nail diseases.

They have published extensively in key venues such as the JDDG Journal der Deutschen Dermatologischen Gesellschaft, Journal of the European Academy of Dermatology and Venereology, Journal of Investigative Dermatology, Frontiers in Immunology, and the British Journal of Dermatology.

Recent significant publications by Enno Schmidt include:

  • European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part II, 2021, Journal of the European Academy of Dermatology and Venereology
  • Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the European Academy of Dermatology and Venereology (EADV), 2020, Journal of the European Academy of Dermatology and Venereology

They have collaborated frequently with scholars such as Detlef Zillikens, Ralf J. Ludwig, Nina van Beek, Christoph M. Hammers, and Khalaf Kridin, demonstrating active engagement in collaborative research within their field.

Main fields of study associated with Enno Schmidt cover 586 publications in medicine overall, with subfields including pathology and forensic medicine (203 publications), rheumatology (152), and genetics (145). Their main topics of research concentrate on autoimmune bullous skin diseases (402 publications), urticaria and related conditions (284), and coagulation and angioedema-related studies (282).

Best Publications

  • Mechanisms of Autoantibody-Induced Pathology.

    Ralf J. Ludwig;Karen Vanhoorelbeke;Frank Leypoldt;Ziya Kaya

  • Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid.

    Enno Schmidt;Karin Obe;Eva-Bettina Bröcker;Detlef Zillikens

  • Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts

    Dedee F. Murrell;Benjamin S. Daniel;Pascal Joly;Luca Borradori

  • Diagnosis and management of pemphigus: Recommendations of an international panel of experts

    Dedee F. Murrell;Sandra Peña;Sandra Peña;Pascal Joly;Branka Marinovic

  • Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany

    Franziska Bertram;Eva‐B. Bröcker;Detlef Zillikens;Detlef Zillikens;Enno Schmidt;Enno Schmidt

  • Clinical features and practical diagnosis of bullous pemphigoid.

    Enno Schmidt;Rocco della Torre;Luca Borradori

  • Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV).

    P. Joly;B. Horvath;Α Patsatsi;S. Uzun

  • Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)

    Hans-Peter Tony;Gerd Burmester;Hendrik Schulze-Koops;Mathias Grunke

  • The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement.

    N. Hunzelmann;E. Genth;T. Krieg;W. Lehmacher

  • Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.

    Kyle T. Amber;Dedee F. Murrell;Enno Schmidt;Pascal Joly

  • IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in bullous pemphigoid: Serum levels of these immunoglobulins reflect disease activity

    Rebekka Döpp;Enno Schmidt;Iakov Chimanovitch;Martin Leverkus

  • Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin.

    Cassian Sitaru;Enno Schmidt;Steffen Petermann;Luminita S. Munteanu

  • Modern diagnosis of autoimmune blistering skin diseases.

    Enno Schmidt;Detlef Zillikens

  • Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial

    Hywel C Williams;Fenella Wojnarowska;Gudula Kirtschig;Gudula Kirtschig;James Mason

  • Rituximab in autoimmune bullous diseases: mixed responses and adverse effects.

    E. Schmidt;C.S. Seitz;S. Benoit;E.B. Bröcker

  • Prevalence and Age Distribution of Pemphigus and Pemphigoid Diseases in Germany.

    Franziska Hübner;Andreas Recke;Detlef Zillikens;Roland Linder

  • Autoantibodies in lichen planus pemphigoides react with a novel epitope within the C-terminal NC16A domain of BP180.

    Detlef Zillikens;Detlef Zillikens;Frederic Caux;Jose M. Mascaro;Ulrich Wesselmann

  • Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies.

    Cassian Sitaru;Cornelia Dähnrich;Christian Probst;Lars Komorowski

  • Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases.

    Michael Hertl;Detlef Zillikens;Luca Borradori;Leena Bruckner-Tuderman

  • Rituximab in refractory autoimmune bullous diseases.

    Schmidt E;Hunzelmann N;Zillikens D;Bröcker Eb

  • Development of ELISA for the specific determination of autoantibodies against envoplakin and periplakin in paraneoplastic pemphigus.

    Christian Probst;Wolfgang Schlumberger;Winfried Stöcker;Andreas Recke

  • Serum autoantibodies against the dermal-epidermal junction in patients with chronic pruritic disorders, elderly individuals and blood donors prospectively recruited.

    N. van Beek;A. Dohse;F. Riechert;V. Krull

Frequent Co-Authors

Detlef Zillikens
Detlef Zillikens University of Lübeck
Ralf Ludwig
Ralf Ludwig University of Rostock
Matthias Goebeler
Matthias Goebeler University of Würzburg
Eva-B. Bröcker
Eva-B. Bröcker University of Würzburg
Takashi Hashimoto
Takashi Hashimoto Osaka Metropolitan University
Marcel F. Jonkman
Marcel F. Jonkman University Medical Center Groningen
Cassian Sitaru
Cassian Sitaru University of Freiburg
Pascal Joly
Pascal Joly University of Rouen
Margitta Worm
Margitta Worm Charité - University Medicine Berlin
Jens Waschke
Jens Waschke Ludwig-Maximilians-Universität München

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Immunology often intersects with various healthcare fields, particularly nursing. For those interested in expanding their expertise, exploring online nursing degree options can be invaluable. Programs like the best online RN programs for non nurses provide a flexible pathway for individuals without a nursing background to enter the field.

Accelerated programs also offer an efficient route to advance your nursing career. The accelerated NP program is designed to help nurses obtain nurse practitioner roles quickly, which can be critical for those interested in acute care or specialized medical fields.

For nurses looking to specialize further, obtaining an acute care certification for FNP allows for a transition from family nurse practitioner roles to acute care settings. This certification is essential for handling complex patient care needs in hospitals and specialized clinics.

If you are considering starting your nursing journey, the easiest ABSN program to get into can provide a more accessible entry point into nursing, often offering accelerated timelines to degree completion.

These education pathways create vital opportunities for those studying Immunology and related healthcare fields to build diverse, impactful careers across clinical and research environments.

Best Scientists Citing Enno Schmidt

Trending Scientists

Recently Published Articles